Literature DB >> 29581173

Structural mechanisms of CFTR function and dysfunction.

Tzyh-Chang Hwang1,2,3, Jiunn-Tyng Yeh4, Jingyao Zhang4,3, Ying-Chun Yu4,2, Han-I Yeh4,2, Samantha Destefano4,2.   

Abstract

Cystic fibrosis (CF) transmembrane conductance regulator (CFTR) chloride channel plays a critical role in regulating transepithelial movement of water and electrolyte in exocrine tissues. Malfunction of the channel because of mutations of the cftr gene results in CF, the most prevalent lethal genetic disease among Caucasians. Recently, the publication of atomic structures of CFTR in two distinct conformations provides, for the first time, a clear overview of the protein. However, given the highly dynamic nature of the interactions among CFTR's various domains, better understanding of the functional significance of these structures requires an integration of these new structural insights with previously established biochemical/biophysical studies, which is the goal of this review.
© 2018 Hwang et al.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29581173      PMCID: PMC5881446          DOI: 10.1085/jgp.201711946

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  232 in total

1.  Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.

Authors:  Yonjung Kim; Marc O Anderson; Jinhong Park; Min Goo Lee; Wan Namkung; A S Verkman
Journal:  Mol Pharmacol       Date:  2015-07-14       Impact factor: 4.436

2.  Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.

Authors:  S Zeltwanger; F Wang; G T Wang; K D Gillis; T C Hwang
Journal:  J Gen Physiol       Date:  1999-04       Impact factor: 4.086

3.  Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs.

Authors:  Wei Wang; Ge Li; John Paul Clancy; Kevin L Kirk
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

4.  Full-open and closed CFTR channels, with lateral tunnels from the cytoplasm and an alternative position of the F508 region, as revealed by molecular dynamics.

Authors:  Jean-Paul Mornon; Brice Hoffmann; Slavica Jonic; Pierre Lehn; Isabelle Callebaut
Journal:  Cell Mol Life Sci       Date:  2014-10-07       Impact factor: 9.261

5.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

6.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

7.  Three-dimensional reconstruction of human cystic fibrosis transmembrane conductance regulator chloride channel revealed an ellipsoidal structure with orifices beneath the putative transmembrane domain.

Authors:  Kazuhiro Mio; Toshihiko Ogura; Muneyo Mio; Hiroyasu Shimizu; Tzyh-Chang Hwang; Chikara Sato; Yoshiro Sohma
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

8.  On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.

Authors:  Ying-Chun Yu; Yoshiro Sohma; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2016-03-23       Impact factor: 5.182

9.  Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance.

Authors:  Marco Rusnati; Davide Sala; Alessandro Orro; Antonella Bugatti; Gabriele Trombetti; Elena Cichero; Chiara Urbinati; Margherita Di Somma; Enrico Millo; Luis J V Galietta; Luciano Milanesi; Paola Fossa; Pasqualina D'Ursi
Journal:  Molecules       Date:  2018-01-08       Impact factor: 4.411

10.  Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker.

Authors:  Alessandro Taddei; Chiara Folli; Olga Zegarra-Moran; Pascale Fanen; A S Verkman; Luis J V Galietta
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

View more
  29 in total

1.  Characterization of Δ(G970-T1122)-CFTR, the most frequent CFTR mutant identified in Japanese cystic fibrosis patients.

Authors:  Kanako Wakabayashi-Nakao; Yingchun Yu; Miyuki Nakakuki; Tzyh-Chang Hwang; Hiroshi Ishiguro; Yoshiro Sohma
Journal:  J Physiol Sci       Date:  2018-06-27       Impact factor: 2.781

2.  Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.

Authors:  Jiunn-Tyng Yeh; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2018-12-02       Impact factor: 5.182

3.  Physiological and pharmacological characterization of the N1303K mutant CFTR.

Authors:  Samantha DeStefano; Maarten Gees; Tzyh-Chang Hwang
Journal:  J Cyst Fibros       Date:  2018-06-07       Impact factor: 5.482

4.  Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.

Authors:  Jeng-Haur Chen
Journal:  J Biol Chem       Date:  2020-02-26       Impact factor: 5.157

5.  Evaluation of 1,2,3-Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX-770 and VX-809.

Authors:  Jake E Doiron; Christina A Le; Britton K Ody; Jonathon B Brace; Savannah J Post; Nathan L Thacker; Harrison M Hill; Gary W Breton; Matthew J Mulder; Sichen Chang; Thomas M Bridges; Liping Tang; Wei Wang; Steven M Rowe; Stephen G Aller; Mark Turlington
Journal:  Chemistry       Date:  2019-02-11       Impact factor: 5.236

6.  Functional stability of CFTR depends on tight binding of ATP at its degenerate ATP-binding site.

Authors:  Han-I Yeh; Ying-Chun Yu; Pei-Lun Kuo; Chun-Kuang Tsai; Hsin-Tuan Huang; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2021-09-17       Impact factor: 6.228

7.  Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>G.

Authors:  Iris A L Silva; Tereza Doušová; Sofia Ramalho; Raquel Centeio; Luka A Clarke; Violeta Railean; Hugo M Botelho; Andrea Holubová; Iveta Valášková; Jiunn-Tyng Yeh; Tzyh-Chang Hwang; Carlos M Farinha; Karl Kunzelmann; Margarida D Amaral
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-07-28       Impact factor: 5.187

8.  Endothelial Extracellular Vesicles in Pulmonary Function and Disease.

Authors:  Eleftheria Letsiou; Natalie Bauer
Journal:  Curr Top Membr       Date:  2018-10-08       Impact factor: 3.049

9.  Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR.

Authors:  Jiunn-Tyng Yeh; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2019-11-02       Impact factor: 5.182

10.  Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator.

Authors:  Onofrio Laselva; Zafar Qureshi; Zhi-Wei Zeng; Evgeniy V Petrotchenko; Mohabir Ramjeesingh; C Michael Hamilton; Ling-Jun Huan; Christoph H Borchers; Régis Pomès; Robert Young; Christine E Bear
Journal:  iScience       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.